In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Silvio Di Castro about his research, as well as the role of compound management in pharmaceutical research.
Dupixent receives FDA approval as first CRSwNP treatment
CRSwNP is a chronic inflammatory disease of the upper airway. Credit: Luisella Planeta LOVE PEACE 💛💙 from Pixabay. The US Food and Drug Administration (FDA)